Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Predictive factors for clinical response to intravitreal bevacizumab in diabetic macular edema
TCTR20200928001Completed
- Sponsor
- Khon Kaen University
- Start
- Mar 2019
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Single-arm trial of bevacizumab in diabetic macular edema (DME), sponsored by Khon Kaen University. Started Mar 2019; status: completed.
02
Drugs
bevacizumab
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on TCTR20200928001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200928001.